This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
immune | responses | 343 |
immune | response | 280 |
public | health | 212 |
- | cell | 210 |
- | time | 122 |
- | vaccination | 102 |
infectious | diseases | 78 |
- | infection | 65 |
viral | vector | 63 |
respiratory | disease | 60 |
live | virus | 54 |
high | levels | 53 |
- | protein | 49 |
recombinant | virus | 47 |
infectious | disease | 41 |
positive | control | 41 |
specific | antibodies | 40 |
viral | infection | 40 |
attenuated | vaccine | 40 |
human | health | 40 |
new | vaccine | 38 |
- | cells | 37 |
- | mouse | 37 |
respiratory | viruses | 37 |
specific | antibody | 37 |
- | control | 35 |
respiratory | infections | 35 |
clinical | development | 33 |
infectious | virus | 33 |
recombinant | protein | 32 |
viral | infections | 32 |
- | level | 31 |
viral | vectors | 30 |
- | vaccine | 29 |
human | disease | 29 |
new | vaccines | 29 |
clinical | disease | 29 |
- | controlled | 27 |
- | sars | 26 |
attenuated | virus | 24 |
clinical | studies | 23 |
live | vaccine | 22 |
viral | proteins | 22 |
attenuated | vaccines | 21 |
immune | cells | 21 |
recombinant | viruses | 21 |
other | studies | 20 |
severe | disease | 20 |
recombinant | vaccine | 20 |
human | vaccine | 20 |
effective | vaccine | 20 |
- | day | 19 |
first | time | 18 |
human | infections | 18 |
effective | vaccines | 17 |
human | cells | 17 |
low | levels | 17 |
first | vaccination | 16 |
high | level | 16 |
live | vaccines | 16 |
- | virus | 15 |
- | years | 15 |
different | groups | 15 |
other | viruses | 14 |
viral | vaccines | 14 |
human | vaccines | 14 |
higher | levels | 14 |
- | year | 13 |
different | time | 13 |
other | vaccines | 13 |
viral | diseases | 13 |
- | influenza | 13 |
- | infections | 12 |
attenuated | influenza | 12 |
attenuated | strains | 12 |
respiratory | virus | 12 |
viral | antigens | 11 |
viral | protein | 11 |
lower | levels | 11 |
clinical | data | 11 |
recombinant | proteins | 11 |
human | influenza | 10 |
positive | results | 10 |
protective | antibody | 10 |
respiratory | infection | 10 |
viral | disease | 10 |
highest | antibody | 9 |
old | group | 9 |
other | groups | 9 |
viral | antigen | 8 |
respiratory | diseases | 8 |
viral | vaccine | 8 |
recombinant | strain | 8 |
recombinant | vaccines | 8 |
human | cell | 8 |
attenuated | strain | 8 |
first | year | 8 |
different | virus | 8 |
attenuated | viruses | 8 |
higher | level | 8 |
human | diseases | 7 |
positive | cells | 7 |
new | developments | 7 |
high | vaccination | 7 |
- | antibodies | 7 |
immune | cell | 6 |
specific | vaccines | 6 |
protective | antigen | 6 |
other | vaccine | 6 |
other | animal | 6 |
new | strain | 6 |
live | sars | 6 |
different | vaccine | 6 |
first | vaccine | 6 |
different | vaccines | 6 |
different | strains | 6 |
- | vector | 6 |
- | health | 6 |
different | animal | 6 |
protective | antibodies | 5 |
severe | influenza | 5 |
positive | controls | 5 |
recombinant | sars | 5 |
other | genes | 5 |
significant | antigen | 5 |
significant | level | 5 |
such | vaccines | 5 |
such | viruses | 5 |
other | strains | 5 |
- | group | 5 |
other | antigens | 5 |
highest | levels | 5 |
high | antibody | 5 |
clinical | study | 5 |
clinical | strains | 5 |
acute | infection | 5 |
- | strain | 5 |
- | development | 5 |
human | antibodies | 5 |
other | vector | 4 |
lower | level | 4 |
lowest | level | 4 |
old | mice | 4 |
old | vaccination | 4 |
recombinant | antigens | 4 |
protective | level | 4 |
protective | levels | 4 |
protective | responses | 4 |
recombinant | antigen | 4 |
low | level | 4 |
lower | antibody | 4 |
new | antigens | 4 |
low | antibody | 4 |
high | vaccine | 4 |
live | vector | 4 |
- | antibody | 4 |
different | cell | 4 |
different | influenza | 4 |
different | viruses | 4 |
different | levels | 4 |
highest | level | 4 |
human | infection | 4 |
human | sars | 4 |
human | studies | 4 |
human | viruses | 4 |
severe | infections | 3 |
other | animals | 3 |
other | diseases | 3 |
other | proteins | 3 |
other | virus | 3 |
protective | antigens | 3 |
protective | vaccine | 3 |
specific | responses | 3 |
severe | vaccine | 3 |
significant | disease | 3 |
significant | levels | 3 |
specific | genes | 3 |
specific | groups | 3 |
specific | virus | 3 |
viral | gene | 3 |
more | vaccines | 3 |
new | influenza | 3 |
other | cells | 3 |
more | time | 3 |
first | group | 3 |
lower | vaccination | 3 |
- | animal | 3 |
- | response | 3 |
- | resulting | 3 |
anti | mouse | 3 |
different | results | 3 |
effective | control | 3 |
different | antigen | 3 |
first | study | 3 |
high | cell | 3 |
human | vaccination | 3 |
important | vaccine | 3 |
infectious | viruses | 3 |
living | animals | 3 |
lower | response | 3 |
new | virus | 2 |
positive | group | 2 |
other | influenza | 2 |
other | infections | 2 |
other | group | 2 |
other | controls | 2 |
other | cell | 2 |
newer | vaccines | 2 |
lowest | vaccine | 2 |
new | strains | 2 |
new | sars | 2 |
new | animal | 2 |
more | times | 2 |
more | sars | 2 |
more | groups | 2 |
more | days | 2 |
positive | result | 2 |
lowest | disease | 2 |
positive | response | 2 |
significant | antibody | 2 |
positive | vaccination | 2 |
protective | response | 2 |
viral | strains | 2 |
viral | genes | 2 |
viral | control | 2 |
such | studies | 2 |
such | data | 2 |
such | antibodies | 2 |
specific | influenza | 2 |
specific | cells | 2 |
specific | cell | 2 |
specific | antigens | 2 |
specific | antigen | 2 |
recombinant | vectors | 2 |
recombinant | vector | 2 |
low | vaccination | 2 |
recombinant | strains | 2 |
recombinant | influenza | 2 |
protective | vaccines | 2 |
low | vaccine | 2 |
different | disease | 2 |
low | disease | 2 |
effective | vector | 2 |
different | vectors | 2 |
different | vaccination | 2 |
different | sars | 2 |
different | days | 2 |
different | antigens | 2 |
clinical | vaccine | 2 |
clinical | response | 2 |
clinical | infection | 2 |
acute | sars | 2 |
acute | influenza | 2 |
- | viruses | 2 |
- | vectors | 2 |
- | vaccines | 2 |
- | strains | 2 |
- | groups | 2 |
- | disease | 2 |
low | cell | 2 |
effective | vaccination | 2 |
- | gene | 2 |
effective | virus | 2 |
higher | vaccine | 2 |
first | day | 2 |
live | viruses | 2 |
important | diseases | 2 |
important | disease | 2 |
important | animals | 2 |
immune | genes | 2 |
human | virus | 2 |
live | influenza | 2 |
higher | vaccination | 2 |
higher | antibody | 2 |
high | virus | 2 |
high | health | 2 |
high | disease | 2 |
first | vaccines | 2 |
higher | responses | 2 |
first | response | 2 |
other | disease | 1 |
old | diseases | 1 |
old | groups | 1 |
older | animals | 1 |
older | groups | 1 |
older | vaccination | 1 |
older | vaccines | 1 |
other | sars | 1 |
other | health | 1 |
other | mouse | 1 |
positive | antibody | 1 |
positive | cell | 1 |
positive | data | 1 |
positive | influenza | 1 |
positive | viruses | 1 |
old | disease | 1 |
new | cell | 1 |
newer | vaccine | 1 |
new | viruses | 1 |
protective | vaccination | 1 |
more | antibodies | 1 |
more | control | 1 |
more | fig | 1 |
more | studies | 1 |
more | vaccine | 1 |
more | virus | 1 |
more | viruses | 1 |
new | antigen | 1 |
new | groups | 1 |
new | infections | 1 |
new | results | 1 |
new | vaccination | 1 |
new | vector | 1 |
new | vectors | 1 |
protective | protein | 1 |
specific | times | 1 |
public | responses | 1 |
specific | vaccine | 1 |
specific | year | 1 |
such | animals | 1 |
such | development | 1 |
such | disease | 1 |
such | diseases | 1 |
such | infections | 1 |
such | results | 1 |
such | sars | 1 |
such | vaccination | 1 |
such | vaccine | 1 |
such | virus | 1 |
viral | antibodies | 1 |
viral | cell | 1 |
viral | influenza | 1 |
viral | levels | 1 |
specific | viruses | 1 |
lower | virus | 1 |
public | vaccination | 1 |
specific | study | 1 |
recombinant | cells | 1 |
recombinant | studies | 1 |
respiratory | antibodies | 1 |
respiratory | cell | 1 |
respiratory | influenza | 1 |
severe | diseases | 1 |
severe | sars | 1 |
significant | cell | 1 |
significant | health | 1 |
significant | responses | 1 |
significant | vaccine | 1 |
specific | control | 1 |
specific | data | 1 |
specific | diseases | 1 |
specific | sars | 1 |
lowest | group | 1 |
human | vaccinations | 1 |
lower | influenza | 1 |
different | control | 1 |
different | mice | 1 |
different | responses | 1 |
different | strain | 1 |
different | studies | 1 |
different | years | 1 |
effective | antibodies | 1 |
effective | antibody | 1 |
effective | influenza | 1 |
effective | levels | 1 |
effective | sars | 1 |
first | antibody | 1 |
first | disease | 1 |
first | studied | 1 |
first | vector | 1 |
first | years | 1 |
different | gene | 1 |
different | antibody | 1 |
low | virus | 1 |
different | animals | 1 |
- | antigen | 1 |
- | antigens | 1 |
- | controlling | 1 |
- | data | 1 |
- | days | 1 |
- | levels | 1 |
- | mice | 1 |
- | times | 1 |
acute | disease | 1 |
acute | diseases | 1 |
acute | response | 1 |
anti | sars | 1 |
clinical | infections | 1 |
clinical | influenza | 1 |
clinical | responses | 1 |
high | influenza | 1 |
high | mouse | 1 |
high | response | 1 |
high | vector | 1 |
important | development | 1 |
important | genes | 1 |
important | protein | 1 |
infectious | animal | 1 |
infectious | antigen | 1 |
infectious | influenza | 1 |
infectious | sars | 1 |
live | cells | 1 |
live | vaccination | 1 |
live | vectors | 1 |
lived | responses | 1 |
low | cells | 1 |
low | infection | 1 |
low | influenza | 1 |
low | protein | 1 |
important | cell | 1 |
immune | mouse | 1 |
human | study | 1 |
highest | cell | 1 |
higher | antigen | 1 |
higher | cell | 1 |
higher | control | 1 |
higher | influenza | 1 |
higher | response | 1 |
higher | virus | 1 |
highest | disease | 1 |
human | response | 1 |
highest | influenza | 1 |
highest | vaccine | 1 |
human | antibody | 1 |
human | controls | 1 |
human | data | 1 |
human | gene | 1 |
viral | vaccination | 1 |